• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药隐形眼镜作为眼部药物传递系统:参考 ISO 标准,对关键隐形眼镜特性评估方法的综述。

Pharmaceutical-loaded contact lenses as an ocular drug delivery system: A review of critical lens characterization methodologies with reference to ISO standards.

机构信息

Ocular Therapeutics Research Group (OTRG), Pharmaceutical & Molecular Biotechnology Research Centre (PMBRC), Waterford Institute of Technology, Waterford City, County Waterford X91 K0EK, Ireland.

Research and Development Department, Bausch + Lomb Ireland Ltd., Waterford City, County Waterford X91 V383, Ireland.

出版信息

Cont Lens Anterior Eye. 2021 Dec;44(6):101487. doi: 10.1016/j.clae.2021.101487. Epub 2021 Aug 3.

DOI:10.1016/j.clae.2021.101487
PMID:34353748
Abstract

Therapeutic contact lenses for ocular drug delivery have received considerable interest as they can potentially enhance ocular bioavailability, increase patient compliance, and reduce side effects. Along with the successful in vitro and in vivo studies on sustained drug delivery through contact lenses, lens critical properties such as water content, optical transparency and modulus have also been investigated. Aside from issues such as drug stability or burst release, the potential for the commercialization of pharmaceutical-loaded lenses can be limited by the alteration of lens physical and chemical properties upon the incorporation of therapeutic or non-therapeutic components. This review outlines advances in the use of pharmaceutical-loaded contact lenses and their relevant characterization methodologies as a potential ocular drug delivery system from 2010 to 2020, while summarizing current gaps and challenges in this field. A key reference point for this review is the relevant ISO standards on contact lenses, relating to the associated characterization methodologies. The content of this review is categorized based on the chemical, physical and mechanical properties of the loaded lens with the shortcomings of such analytical technologies examined.

摘要

治疗性接触镜在眼部药物传递方面受到了相当大的关注,因为它们有可能提高眼部生物利用度、增加患者依从性并降低副作用。随着通过接触镜进行持续药物传递的体外和体内研究的成功,水含量、光学透明度和模量等镜片关键特性也得到了研究。除了药物稳定性或爆发释放等问题外,由于治疗或非治疗成分的掺入会改变镜片的物理和化学性质,因此载药镜片的商业化潜力可能会受到限制。本文综述了 2010 年至 2020 年期间,载药接触镜及其相关特征化方法在作为潜在眼部药物传递系统方面的应用进展,同时总结了该领域目前存在的差距和挑战。本文的一个关键参考点是与相关特征化方法有关的接触镜相关 ISO 标准。本文综述的内容是根据载药镜片的化学、物理和机械性能进行分类的,并对这些分析技术的缺点进行了检查。

相似文献

1
Pharmaceutical-loaded contact lenses as an ocular drug delivery system: A review of critical lens characterization methodologies with reference to ISO standards.载药隐形眼镜作为眼部药物传递系统:参考 ISO 标准,对关键隐形眼镜特性评估方法的综述。
Cont Lens Anterior Eye. 2021 Dec;44(6):101487. doi: 10.1016/j.clae.2021.101487. Epub 2021 Aug 3.
2
Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery.载药纳米粒子隐形眼镜用于眼部给药的研究进展与挑战。
Int J Pharm. 2021 Oct 25;608:121090. doi: 10.1016/j.ijpharm.2021.121090. Epub 2021 Sep 14.
3
Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions.用于治疗不同眼部疾病的治疗性隐形眼镜的进展。
J Pers Med. 2023 Nov 3;13(11):1571. doi: 10.3390/jpm13111571.
4
Evaluation of commercial soft contact lenses for ocular drug delivery: A review.用于眼部药物递送的商用软性隐形眼镜的评估:综述
Acta Biomater. 2020 Oct 1;115:60-74. doi: 10.1016/j.actbio.2020.08.025. Epub 2020 Aug 25.
5
Ofloxacin-Loaded Niosome-Laden Contact Lens: Improved Properties of Biomaterial for Ocular Drug Delivery.载氧氟沙星囊泡的隐形眼镜:眼部药物输送生物材料性能的改善。
AAPS PharmSciTech. 2021 Dec 1;23(1):6. doi: 10.1208/s12249-021-02157-w.
6
Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.治疗性隐形眼镜治疗角膜和眼表疾病:延长和靶向药物输送的进展。
Int J Pharm. 2023 May 10;638:122740. doi: 10.1016/j.ijpharm.2023.122740. Epub 2023 Feb 19.
7
Therapeutic contact lenses for ophthalmic drug delivery: major challenges.眼科药物递送治疗性接触镜:主要挑战。
J Biomater Sci Polym Ed. 2020 Mar;31(4):549-560. doi: 10.1080/09205063.2020.1712175. Epub 2020 Jan 14.
8
Controlled release of naringenin from soft hydrogel contact lens: An investigation into lens critical properties and in vitro release.从软性水凝胶隐形眼镜中控制柚皮苷的释放:对隐形眼镜关键性能和体外释放的研究。
Int J Pharm. 2022 Jun 10;621:121793. doi: 10.1016/j.ijpharm.2022.121793. Epub 2022 May 6.
9
Tailored gatifloxacin Pluronic® F-68-loaded contact lens: Addressing the issue of transmittance and swelling.载有加替沙星的定制型 Pluronic® F-68 隐形眼镜:解决透光率和肿胀问题。
Int J Pharm. 2020 May 15;581:119279. doi: 10.1016/j.ijpharm.2020.119279. Epub 2020 Mar 30.
10
Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.通过负载维生素 E 的隐形眼镜控制递送达比非尼酮可改善角膜炎症。
Drug Deliv Transl Res. 2018 Oct;8(5):1114-1126. doi: 10.1007/s13346-018-0541-5.

引用本文的文献

1
Biodegradable Contact Lenses for Targeted Ocular Drug Delivery: Recent Advances, Clinical Applications, and Translational Perspectives.用于靶向眼部药物递送的可生物降解隐形眼镜:最新进展、临床应用及转化前景
Molecules. 2025 Jun 10;30(12):2542. doi: 10.3390/molecules30122542.
2
Application of Silicone in Ophthalmology: A Review.硅酮在眼科中的应用:综述
Materials (Basel). 2024 Jul 12;17(14):3454. doi: 10.3390/ma17143454.
3
Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
载药隐形眼镜中布林佐胺和噻吗洛尔的共递送:体外和体内评价。
Pharm Res. 2024 Mar;41(3):531-546. doi: 10.1007/s11095-024-03672-8. Epub 2024 Feb 16.
4
Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.研制载有溴莫尼定的尼欧索姆隐形眼镜用于延长释放及有望成为治疗青光眼的新传递系统。
Daru. 2024 Jun;32(1):161-175. doi: 10.1007/s40199-023-00500-z. Epub 2023 Dec 29.
5
Contact lens as an emerging platform for ophthalmic drug delivery: A systematic review.隐形眼镜作为眼科药物递送的新兴平台:一项系统评价。
Asian J Pharm Sci. 2023 Sep;18(5):100847. doi: 10.1016/j.ajps.2023.100847. Epub 2023 Sep 27.
6
Technological Advances in a Therapy of Primary Open-Angle Glaucoma: Insights into Current Nanotechnologies.原发性开角型青光眼治疗中的技术进展:对当前纳米技术的见解
J Clin Med. 2023 Sep 6;12(18):5798. doi: 10.3390/jcm12185798.
7
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions.基因治疗视网膜退行性疾病:进展、挑战与未来方向。
Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):39. doi: 10.1167/iovs.64.7.39.
8
Application of Convergent Science and Technology toward Ocular Disease Treatment.融合科学技术在眼部疾病治疗中的应用。
Pharmaceuticals (Basel). 2023 Mar 16;16(3):445. doi: 10.3390/ph16030445.
9
Biogenic silver nanoparticles (AgNPs) from leaves: An effective antibiofilm agent against ATCC 23235.来自树叶的生物源银纳米颗粒(AgNPs):一种针对ATCC 23235的有效抗生物膜剂。
Front Chem. 2023 Mar 7;11:1118454. doi: 10.3389/fchem.2023.1118454. eCollection 2023.
10
Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses.用于眼部疾病治疗的合成与天然眼部给药系统开发中的创新:聚焦载药眼用插入物、隐形眼镜和人工晶状体。
Pharmaceutics. 2023 Feb 13;15(2):625. doi: 10.3390/pharmaceutics15020625.